16
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists

, , , , , , , , , , , , & show all
Pages 47-53 | Received 16 Aug 2006, Accepted 16 May 2007, Published online: 12 Jul 2009

References

  • Australian Institute of Health and Welfare (AIHW). Alcohol and other drug treatment services in Australia 2004 – 05: report on the national minimum data set. AIHW, Canberra 2006, Drug Treatment Series 5. AIHW cat. no. HSE 43
  • Australian Institute of Health and Welfare (AIHW). Alcohol and other drug treatment services in Australia 2001 – 02: report on the national minimum data set. AIHW, Canberra 2003, Drug Treatment Series 2. AIHW cat. no. HSE 28
  • Matheson C, Bond C M, Pitcairn J. Community pharmacy services for drug misusers in Scotland: what difference does 5 years make?. Addiction 2002; 97: 1405–1411
  • Hurley M. Guide for pharmacists: addiction treatment and maintenance pharmacotherapy (methadone and buprenorphine) programs in South Australia. Parkside: Drug and Alcohol Services Council, Government of South Australia. 2004
  • Healthcare Management Advisors. Development, implementation and evaluation of funding model options for the dispensing of pharmacotherapies for opioid dependence in community pharmacy. Pharmacy Guild of Australia. 2003, Unpublished document
  • Hotham E, Roche A, Skinner N, Dollman B. The general practitioner pharmacotherapy prescribing workforce: examining sustainability from a systems perspective. Drug Alcohol Rev 2005; 24: 1–8
  • Muhleisen P, Lintzeris N, Koutroulis G, et al. Evaluation of methadone dispensing in community pharmacies in Victoria. Aust Pharm 1998; 17(suppl)7–12
  • Peterson G M. Drug misuse and harm reduction: pharmacy's magnificent contribution, but at what cost?. J Clin Pharm Ther 1999; 24: 165–169
  • Le P P, Hotham E D. Exploring the dissonance between business and public health policy: pharmacy and the provision of opioid pharmacotherapies and clean needles in rural settings. Int J Pharm Pract 2006; 14: 63–70
  • Australian Bureau of Statistics (ABS). Australian demographic statistics. ABS cat. no. 3101.0. ABS, Canberra 2004
  • Berbatis C G, Sunderland V B. The role of community pharmacy in methadone maintenance treatment: an evaluation through a literature review, prospective, retrospective and other studies conducted in Australia and overseas from 1998 – 2000. Australian Association of Consultant Pharmacy, Barton 2001
  • Jesson J, Wilson K, Barton A, Pocock R. Exploring the potential for supervised methadone consumption and shared care contracts with drug misusers. Pharm J 2000; 265: R37, (Pharmacy Practice Research Supplement, Sept. 16)
  • SPSS Inc. SPSS release 12.0. SPSS Inc., Chicago, IL 2003
  • Sheridan J, Cronin F. Supervised self-administration of methadone at community pharmacies: the introduction of a new service. Pharm J 2002; 268: 471–474
  • Muhleisen P, Panjari M, Lee N. Buprenorphine dispensing in a cohort of community pharmacies in Victoria. Aust Pharm 2003; 22: 229–234
  • Matheson C, Bond C M, Mollison J. Attitudinal factors associated with community pharmacists' involvement in services for drug misusers. Addiction 1999; 94: 1349–1359

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.